Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05876858 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EXPLORER Total Body PET/CT Imaging for Myofascial Pain

StatusActive, Not Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Sep 2026 → Sep 2027
See other at-risk trials from University of California, Davis

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Sep 2026 to Sep 2027
    • Eligibility criteria expanded, about 33 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: Sep 2025 to Sep 2026
    • Study completion date: Sep 2026 to Sep 2027
    • Site contact updated
    v5
  5. Trial status: Suspended to Recruiting
    • Site details revised
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Recruiting to Suspended Sponsor's reason: Tracer currently unavailable; hope to obtain again in the near future
    • Site details revised
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of May 2023 to Jun 13, 2023
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective of this study is to establish novel measures derived from Total-body-Positron Emission Tomography/Computed Tomography (TB-PET/CT) as quantitative biomarkers for the investigation of myofascial pain. The TB-PET/CT assessed measures are those reflective of myofascial tissue metabolism, perfusion, and fatty infiltration.
Trial Details
NCT Number NCT05876858
Lead Sponsor University of California, Davis
Collaborators: National Institutes of Health (NIH), National Center for Complementary and Integrative Health (NCCIH)
Conditions
(from sponsor)		 Myofascial Pain
Enrollment 53 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov